- Home
- SCLX vs ARKR Comparison
SCLX vs ARKR Comparison
Compare SCLX & ARKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLX
- ARKR
- Stock Information
- Founded
- SCLX 2011
- ARKR 1983
- Country
- SCLX United States
- ARKR United States
- Employees
- SCLX N/A
- ARKR N/A
- Industry
- SCLX Biotechnology: Pharmaceutical Preparations
- ARKR Restaurants
- Sector
- SCLX Health Care
- ARKR Consumer Discretionary
- Exchange
- SCLX Nasdaq
- ARKR Nasdaq
- Market Cap
- SCLX 28.4M
- ARKR 31.4M
- IPO Year
- SCLX N/A
- ARKR N/A
- Fundamental
- Price
- SCLX $4.67
- ARKR $11.00
- Analyst Decision
- SCLX Strong Buy
- ARKR
- Analyst Count
- SCLX 4
- ARKR 0
- Target Price
- SCLX $396.67
- ARKR N/A
- AVG Volume (30 Days)
- SCLX 206.3K
- ARKR 14.1K
- Earning Date
- SCLX 05-23-2025
- ARKR 05-12-2025
- Dividend Yield
- SCLX N/A
- ARKR 1.77%
- EPS Growth
- SCLX N/A
- ARKR N/A
- EPS
- SCLX N/A
- ARKR N/A
- Revenue
- SCLX $56,590,000.00
- ARKR $178,516,000.00
- Revenue This Year
- SCLX $115.30
- ARKR N/A
- Revenue Next Year
- SCLX $73.33
- ARKR N/A
- P/E Ratio
- SCLX N/A
- ARKR N/A
- Revenue Growth
- SCLX 21.07
- ARKR N/A
- 52 Week Low
- SCLX $3.60
- ARKR $8.25
- 52 Week High
- SCLX $80.50
- ARKR $17.76
- Technical
- Relative Strength Index (RSI)
- SCLX 39.15
- ARKR 56.58
- Support Level
- SCLX $3.92
- ARKR $10.60
- Resistance Level
- SCLX $6.13
- ARKR $11.73
- Average True Range (ATR)
- SCLX 0.69
- ARKR 0.87
- MACD
- SCLX 0.13
- ARKR 0.20
- Stochastic Oscillator
- SCLX 32.56
- ARKR 53.85
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About ARKR Ark Restaurants Corp.
Ark Restaurants Corp owns and operates around 17 restaurants and bars, 16 fast food concepts, and catering operations in the USA. The Las Vegas operations include New York Hotel & Casino Resort, hotel room service operations, banquet facilities, employee dining room, food court concepts, and a restaurant within the Planet Hollywood Resort and Casino. It operates a restaurant and a bar in the Resorts Atlantic City Hotel and Casino and a restaurant in the Tropicana Hotel and Casino. The Florida operations include The Rustic Inn in Dania Beach, Shuckers in Jensen Beach, JB's on the Beach in Deerfield Beach, The Blue Moon Fish Company in Fort Lauderdale, and fast food facilities in Tampa and Hollywood. In Alabama, it operates Original Oyster Houses in Gulf Shores and Spanish Fort.